Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.7.0.1
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Consolidated Statements of Operations [Abstract]    
Sales $ 1,778,037 $ 236,000
Cost of Sales 4,312,088 464,377
Gross loss (2,534,051) (228,377)
Operating Expenses    
Selling, general and administrative 2,107,582 1,170,992
Research and development 3,243,322 2,940,940
Total operating expenses 5,350,904 4,111,932
Interest expense, net 35,651 39,703
Net loss $ (7,920,606) $ (4,380,012)
Basic and diluted loss per share $ (0.24) $ (0.23)
Weighted average number of common shares outstanding 32,965,419 21,580,604